The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Harper Philip R since 2005.
The trader's CIK number is 1181073.
At the time of the last reporting, Harper Philip R was the Director of Aevi Genomic Medicine, Llc. (stock ticker symbol CERC).
Also see all insider trading activities at Aevi Genomic Medicine, Llc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | ACAS | 0 | $0 | 109,391 | $1,648,638 | 0 | $0 |
| 2014 | ACAS | 0 | $0 | 343,600 | $5,292,414 | 0 | $0 |
| 2013 | ACAS | 0 | $0 | 15,000 | $221,415 | 0 | $0 |
| 2011 | ACAS | 20,000 | $173,000 | 0 | $0 | 0 | $0 |
| 2010 | ACAS | 40,000 | $205,760 | 0 | $0 | 0 | $0 |
| 2009 | ACAS | 380,900 | $240,846 | 0 | $0 | 0 | $0 |
| 2008 | ACAS | 66,840 | $1,096,404 | 0 | $0 | 0 | $0 |
| 2007 | ACAS | 100,000 | $4,230,499 | 0 | $0 | 0 | $0 |
| 2006 | ACAS | 169,473 | $5,881,125 | 0 | $0 | 0 | $0 |
| 2005 | ACAS | 59,289 | $2,281,440 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | GNMC | 1,173,137 | $2,020,971 | 0 | $0 | 0 | $0 |
1. American Capital Strategies Ltd (ACAS)
2. Aevi Genomic Medicine, Llc (GNMC)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-12-03 | ACAS | Sale | 70,000 | 15.31 | 1,071,560 |
| 2015-03-12 | ACAS | Sale | 39,391 | 14.65 | 577,078 |
| 2014-12-11 | ACAS | Sale | 43,600 | 14.71 | 641,574 |
| 2014-03-07 | ACAS | Sale | 120,000 | 15.51 | 1,860,720 |
| 2014-02-25 | ACAS | Sale | 60,000 | 15.25 | 915,000 |
| 2014-02-20 | ACAS | Sale | 120,000 | 15.63 | 1,875,120 |
| 2013-12-12 | ACAS | Sale | 15,000 | 14.76 | 221,415 |
| 2011-06-10 | ACAS | Buy | 20,000 | 8.65 | 173,000 |
| 2010-08-18 | ACAS | Buy | 40,000 | 5.14 | 205,760 |
| 2009-03-13 | ACAS | Buy | 30,900 | .89 | 27,346 |
| 2009-03-06 | ACAS | Buy | 350,000 | .61 | 213,500 |
| 2008-11-20 | ACAS | Buy | 10,000 | 4.64 | 46,400 |
| 2008-11-13 | ACAS | Buy | 9,000 | 5.79 | 52,110 |
| 2008-09-05 | ACAS | Buy | 47,840 | 20.86 | 997,894 |
| 2007-03-07 | ACAS | Buy | 50,000 | 43.38 | 2,169,000 |
| 2007-03-05 | ACAS | Buy | 50,000 | 41.23 | 2,061,499 |
| 2006-05-08 | ACAS | Buy | 49,388 | 33.88 | 1,673,265 |
| 2006-05-04 | ACAS | Buy | 27,777 | 33.29 | 924,696 |
| 2006-05-05 | ACAS | Buy | 17,308 | 33.52 | 580,164 |
| 2006-02-16 | ACAS | Buy | 75,000 | 36.04 | 2,703,000 |
| 2005-11-25 | ACAS | Buy | 59,289 | 38.48 | 2,281,440 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-09-01 | GNMC | Buy | 83,775 | 1.20 | 100,530 |
| 2017-08-22 | GNMX | Buy | 4,661 | 1.20 | 5,593 |
| 2017-08-23 | GNMX | Buy | 5,700 | 1.20 | 6,840 |
| 2017-08-10 | GNMX | Buy | 20,470 | 1.19 | 24,359 |
| 2017-03-22 | GNMX | Buy | 1,000,000 | 1.79 | 1,790,000 |
| 2017-03-23 | GNMX | Buy | 4,705 | 1.60 | 7,528 |
| 2017-03-24 | GNMX | Buy | 53,826 | 1.60 | 86,121 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Harper Philip R (Director of Aevi Genomic Medicine, Llc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.